Tower Research Capital (TRC)’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,453
| Closed | -$13.5K | – | 6398 |
|
|
2023
Q3 | $13.5K | Buy |
3,453
+135
| +4% | +$529 | ﹤0.01% | 3777 |
|
|
2023
Q2 | $10.8K | Buy |
3,318
+1,702
| +105% | +$5.53K | ﹤0.01% | 4038 |
|
|
2023
Q1 | $6K | Buy |
1,616
+1,350
| +508% | +$5.01K | ﹤0.01% | 4916 |
|
|
2022
Q4 | $9K | Buy |
266
+2
| +0.8% | +$68 | ﹤0.01% | 4336 |
|
|
2022
Q3 | $11K | Sell |
264
-34
| -11% | -$1.42K | ﹤0.01% | 4495 |
|
|
2022
Q2 | $13K | Buy |
298
+155
| +108% | +$6.76K | ﹤0.01% | 4250 |
|
|
2022
Q1 | $10K | Sell |
143
-191
| -57% | -$13.4K | ﹤0.01% | 4396 |
|
|
2021
Q4 | $40K | Buy |
334
+106
| +46% | +$12.7K | ﹤0.01% | 2959 |
|
|
2021
Q3 | $32K | Buy |
228
+109
| +92% | +$15.3K | ﹤0.01% | 3333 |
|
|
2021
Q2 | $33K | Buy |
119
+23
| +24% | +$6.38K | ﹤0.01% | 3406 |
|
|
2021
Q1 | $21K | Sell |
96
-75
| -44% | -$16.4K | ﹤0.01% | 3862 |
|
|
2020
Q4 | $41K | Sell |
171
-668
| -80% | -$160K | ﹤0.01% | 3312 |
|
|
2020
Q3 | $88K | Buy |
839
+689
| +459% | +$72.3K | ﹤0.01% | 3243 |
|
|
2020
Q2 | $15K | Buy |
150
+120
| +400% | +$12K | ﹤0.01% | 3840 |
|
|
2020
Q1 | $2K | Sell |
30
-56
| -65% | -$3.73K | ﹤0.01% | 2678 |
|
|
2019
Q4 | $7K | Sell |
86
-117
| -58% | -$9.52K | ﹤0.01% | 2556 |
|
|
2019
Q3 | $24K | Buy |
203
+198
| +3,960% | +$23.4K | ﹤0.01% | 2352 |
|
|
2019
Q2 | $1K | Sell |
5
-233
| -98% | -$46.6K | ﹤0.01% | 3524 |
|
|
2019
Q1 | $38K | Buy |
238
+134
| +129% | +$21.4K | ﹤0.01% | 1914 |
|
|
2018
Q4 | $27K | Sell |
104
-93
| -47% | -$24.1K | ﹤0.01% | 1722 |
|
|
2018
Q3 | $48K | Buy |
197
+111
| +129% | +$27K | ﹤0.01% | 1794 |
|
|
2018
Q2 | $20K | Buy |
+86
| New | +$20K | ﹤0.01% | 2445 |
|